Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel

Zagami, P. & Carey, L. A. Triple negative breast cancer: pitfalls and progress. NPJ Breast ...

Your CDK4/6 Inhibitor Treatment Cycle for Metastatic Breast Cancer: A Practical Guide

During the first three weeks of the four-week cycle, you’ll take Ibrance or Kisqali every ...

Chicken Breast vs. Turkey Breast: Which Protein Is Healthier?

Calories are essential to give your body the energy it needs, but the source matters. ...

BNIP3 is a key driver of breast cancer progression and a novel glycolysis-regulating biomarker

Data acquisition Clinical and patient data from BC were downloaded from The Cancer Genome Atlas ...